Expression profiling of genes in rheumatoid fibroblast‑like synoviocytes regulated by Fas ligand via cDNA microarray analysis

• Published in: Experimental and therapeutic medicine Vol. 22; no. 3
• Main Authors: Fukuda, Koji, Miura, Yasushi, Maeda, Toshihisa, Hayashi, Shinya, Matsumoto, Tomoyuki, Kuroda, Ryosuke
• Format: Journal Article
• Language: English
• Published: Athens Spandidos Publications 01-09-2021; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Apoptosis; Connective tissue cells; Data analysis; Development and progression; DNA microarrays; Fibroblasts; Gene expression; Genetic aspects; Genomes; Health aspects; Hyperplasia; Kinases; Ligands; Medical research; Medicine, Experimental; Metabolism; Mutation; Pathogenesis; Rheumatoid arthritis; Software; Statistical analysis; Synovial membranes; Tumor necrosis factor; Tumor necrosis factor-TNF; Japan
• ISSN: 1792-0981; 1792-1015
• DOI: 10.3892/etm.2021.10432

Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation in synovial tissues. Hyperplasia of synovial tissues leads to the formation of pannus that invades the joint cartilage and bone, resulting in joint destruction. Fas ligand (FasL), which is a member of the tumor necrosis factor superfamily, contributes to the pathogenesis of autoimmune diseases, including RA. The current study attempted to identify genes whose expressions in rheumatoid fibroblast-like synoviocytes (RA-FLS) were regulated by FasL, using cDNA microarray. A total of four individual lines of primary cultured RA-FLS were incubated either with recombinant human FasL protein or PBS as an unstimulated control for 12 h. Gene expression was detected using a microarray assay. The results revealed the expression profiles of genes in RA-FLS regulated by Fas and investigated the functions of the genes that were regulated. Among the genes in this profile, the mRNA expression changes of the following genes were indicated to be of note using RT-qPCR: Dual specificity phosphatase 6, epiregulin, interleukin 11, angiopoietin-like 7, protein inhibitor of activated STAT 2 and growth differentiation factor 5. These genes may affect the pathogenesis of RA by affecting apoptosis, proliferation, cytokine production, cytokine-induced inflammation, intracellular signaling, angiogenesis, bone destruction and chondrogenesis. To the best of our knowledge, the current study is the first study to reveal the expression profile of genes in RA-FLS regulated by FasL. The data demonstrated that FasL may regulate the expression of a number of key molecules in RA-FLS, thus affecting RA pathogenesis. Further studies of the genes detected may improve the understanding of RA pathogenesis and provide novel treatment targets for RA.